Table 3

- Distribution of susceptible antifungals in coronavirus disease-19 positive and coronavirus disease-19 negative patients.

AntifungalCOVID-19 (+)COVID-19 (-)P-valueχ2df
Anidulafungin70 (98.5)41 (97.6)0.1646.514
Caspofungin68 (95.7)41 (97.6)
Vorikonazol60 (84.5)23 (54.7)
Micafungin69 (97.1)41 (97.6)
Flukonazol50 (70.4)15 (35.7)
  • Values are presented as numbers and percentages (%). COVID-19: coronavirus disease-19, χ2: Ki-kare, df: degree of freedom